Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma - Rossana Di Staso; Beatrice Casadei; Frederick L. Locke; Michael Jain; Timothy J. Voorhees; Adam S. Kittai; Mariana Bastos-Oreiro; Antonio Gutiérrez; Alejandro Martin Garcia-Sancho; Maria Jose Terol; Monica Mead; Michael J. Maranzano; et al. (Blood Cancer Journal)